Related Experiment Video
Updated: Jun 28, 2026

Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs
Published on: December 27, 2016
Reduced expression and defective modulation of TNF receptor/ligand family molecules on proB-ALL blasts
A Troeger1, L Glouchkova, G Escherich
1Clinic for Pediatric-Oncology, -Hematology and Clinical Immunology, Heinrich Heine University Düsseldorf, Germany. troeger@med.uni-duesseldorf.de
Insights
Pediatric proB acute lymphoblastic leukemia (ALL) shows lower TNF receptor expression, impacting treatment response and relapse risk. This finding highlights potential new therapeutic targets for high-risk B-cell precursor ALL.
Area of Science:
- Immunology
- Pediatric Oncology
- Molecular Biology
Background:
- B cell precursor acute lymphoblastic leukemia (BCP-ALL) generally has a good prognosis, but a subset of pediatric patients with proB-ALL remains a therapeutic challenge.
- These patients often experience relapse due to impaired treatment response and are classified into high-risk groups requiring intensified chemotherapy.
- Long-term prognosis is also influenced by immunological control, with high expression of the TNF receptor CD40 potentially preventing late relapses in BCP-ALL.
Purpose of the Study:
- To investigate the baseline expression and CD40-mediated modulation of TNF receptor and costimulatory molecules in pediatric proB-ALL.
- To compare the TNF receptor status on proB-ALL blasts with that of more mature preB- and c-ALL blasts.
Main Methods:
- Flow cytometry (FACS) analysis was performed on samples from 5 patients with proB-ALL, 8 with preB-ALL, and 22 with c-ALL.
- Baseline expression and CD40-mediated modulation of TNF receptor and costimulatory molecules were determined.
Main Results:
- Pediatric proB-ALL blasts exhibit significantly lower baseline expression of TNF receptor and costimulatory molecules compared to more mature precursor B-ALL blasts.
- The capacity for CD40-induced modulation of these molecules is also diminished in proB-ALL blasts.
Conclusions:
- The reduced expression and defective response to CD40 ligand stimulation in proB-ALL may reflect their immature phenotype.
- This defect, along with increased chemoresistance, could contribute to the poorer prognosis in these patients by facilitating escape from apoptosis and immune surveillance.
Background:
There is a subgroup of pediatric patients with an immature immunophenotype of proB-ALL that still poses a therapeutic challenge, even if the overall prognosis in B cell precursor acute lymphoblasic leukemia (BCP-ALL) is very good. Due to impaired treatment response these patients are prone to suffer relapse and are thus by definition stratified into the clinically defined high risk group receiving intensified chemotherapy. Besides response to chemotherapy long term prognosis is also influenced by immunological control mechanisms. Thus, high expression of the TNF receptor CD40 has been shown to prevent particularly late relapse in BCP-ALL suggesting a pivotal role of this regulatory molecule for maintenance of the remission status.
Patients And Methods:
We therefore determined the baseline expression and CD40-mediated modulation of TNF receptor and costimulatory molecules in 5 patients with proB-ALL, 8 with preB-ALL and 22 with c-ALL performing FACS analysis. We particularly compared the TNF receptor status on proB-ALL blasts to the expression on more mature preB- and c-ALL blasts.
Results:
Here, we demonstrate for the first time a significantly lower baseline expression and CD40-induced modulation capacity of TNF receptor and costimulatory molecules in pediatric proB-ALL compared to more mature precursor B-ALL blasts.
Conclusion:
The lower expression and defective capacity of proB-ALL blasts to respond to CD40 ligand stimulation might resemble the immature feature of these blasts and besides increased chemoresistance contribute to the impaired prognosis of these patients due to escape from apoptosis and immunological control mechanisms.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
TGF - β Signaling Pathway
Abnormal Proliferation
Regulation of Hematopoietic Stem Cells
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
